ROYAL BANK OF CANADA - SILVERBACK THERAPEUTICS INC ownership

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of SILVERBACK THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$15,000
-37.5%
3,842
+6.9%
0.00%
Q2 2023$24,0003,594
+71780.0%
0.00%
Q1 2023$050.0%0.00%
Q4 2022$0
-100.0%
5
-99.6%
0.00%
Q1 2022$4,000
-85.7%
1,260
-69.4%
0.00%
Q4 2021$28,000
+21.7%
4,121
+76.1%
0.00%
Q3 2021$23,000
-25.8%
2,340
+135.6%
0.00%
Q2 2021$31,000
-39.2%
993
-14.2%
0.00%
Q1 2021$51,0001,1580.00%
Other shareholders
SILVERBACK THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
SR ONE CAPITAL MANAGEMENT, LP 4,012,903$15,168,7737.77%
Nextech Invest Ltd. 1,910,029$7,219,9102.19%
K2 PRINCIPAL FUND, L.P. 2,552,062$9,646,7942.02%
Charles Schwab Trust Co 4,246,071$16,050,1481.81%
Sio Capital Management, LLC 1,105,911$4,180,3441.29%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 11,077,927$41,874,5640.92%
SECTORAL ASSET MANAGEMENT INC 1,049,191$3,965,9420.77%
Orbimed Advisors 9,240,887$34,930,5530.74%
RA Capital Management 9,459,678$35,757,5830.70%
K2 PRINCIPAL FUND, L.P. 688,900$2,604,0420.55%
View complete list of SILVERBACK THERAPEUTICS INC shareholders